We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Aventis, Mylan Debate Validity Of Prostate Cancer Treatment In Patent Appeal

Mealey's (May 11, 2018, 1:09 PM EDT) -- WASHINGTON, D.C. — Mylan Laboratories Ltd. on April 24 defended a final written decision of the Patent Trial and Appeal Board, which deemed obvious various claims of an Aventis Pharma S.A....
To view the full article, register now.